INS and kidney disorder: At the final evaluation, both groups notably increased the number of antihypertensives, the use of ACEIs, ARBs, insulin+oral hypoglycemic drugs, statins, fibrates, and aspirin (at cardioprotective dose); however, in patients with overt nephropathy the change was significant only in the case of the first two variables.